Zacks Investment Research downgraded shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) from a hold rating to a sell rating in a research note published on Thursday. According to Zacks, “Catalyst has a limited …
Middle East
Catalyst Pharmaceuticals is having an incredible day in the market today, and for good reason. Piper Jaffray, one of the most trusted analysts weighing in on market activity, weighed in on the stock. Judging by the reaction in …
Piper Jaffray
Shares of Miami-based Opko Health (Nasdaq: OPK) and Coral Gables-based Catalyst Pharmaceuticals (Nasdaq: CPRX), among other publicly traded ... and Boca Raton-based TherapeuticsMD's (NYSE: TXMD) stock
drug companies
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) investors have a smile on their faces Thursday morning, after …
NASDAQ
This is a technical analysis stock rating for Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) . The company has a three bull technical rating which indicates an inflection point. With the current stock price and the moving …
NASDAQ
Nexvet Biopharma Plc (NVET): NVET stock is down 2.01% today. Catalyst Pharmaceutical Partners (CPRX): CPRX stock is up 2.72% today. Fortress Biotech Inc (FBIO): FBIO stock is up 1.75% today. Cidara …
Catalyst Pharmaceuticals, Inc. CPRX is scheduled to report third-quarter 2016 results on Nov 9, after market close. Last quarter, the company's loss was narrower than expected. Catalyst's performance so far has been …
NASDAQ2mon
NASDAQ
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. Too many investors have a fundamental misunderstanding about the significance of …
Stock
Catalyst Pharmaceuticals, Inc. CPRX was a big mover last session, as the company saw its shares rise over 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal …
Catalyst Pharmaceuticals, Inc. (CPRX - Free Report) was a big mover last session, as its shares rose almost 7% on the day. The rally came on the back of the company’s agreement with the FDA on a confirmatory Phase 3 …
ZACKS7mon